The global veterinary vaccines market is anticipated to reach value of USD 12.75 Billion by 2027, according to a current analysis by Emergen Research. The veterinary/animal vaccines market is likely to expand rapidly, due to the growing use of vaccines to treat zoonotic disorders and increasing inclination to use fewer antibiotics. Moreover, the rising rate of incidence of livestock disorders is anticipated to propel the veterinary vaccines market further during the forecast period.
Key questions answered in the report
What will be the market size in terms of value and volume in the next five years?
Which segment is currently leading the market?
In which region will the market find its highest growth?
Which players will take the lead in the market?
What are the key drivers and restraints of the market’s growth?
You Can Download Free Sample PDF Copy of Veterinary Vaccines Market at https://www.emergenresearch.com/request-sample/426
Data triangulation and market breakdown
Research assumptions Research data including primary and secondary data
Primary data includes breakdown of primaries and key industry insights
Secondary data includes key data from secondary sources
Key Highlights of Report
In January 2020, Automazioni VX, Inc. entered into a cooperative agreement with Merck Animal Health, a division of Merck KGaA. The collaboration was aimed to launch Innoject Pro, a uniquely developed technology for subcutaneous injection vaccination of chicken. The technology can be utilized in conjunction with the Innovax vaccine by Merck Animal Health, which is used to safeguard poultry from bacterial infections.
The poultry segment is expected to lead the global veterinary vaccines market throughout the forecast period, expanding at a CAGR of 7.0%. The increased need for risk-free pet food, associated with a growing focus on developing new animal protection approaches, is estimated to drive the segment during the forecast period.
The injection segment is projected to retain the largest market share throughout the forecast period. Growth of the segment is attributable to increasing use of injection vaccines for protection of animal health. Injection vaccines play a crucial role in preventing and controlling the dissemination of disease outbreaks in both farm animals and livestock.
Throughout the forecast period, the inactivated segment is expected to dominate the market for veterinary vaccines. Inactivated vaccines are free from bacteria and suitable for rehabilitation, except in case of immunocompetent patients. These vaccines are usually compressed, which makes their shipping and preserving simple.
Due to growing prevalence of viral infections among livestock, including the Nipah virus infection, avian influenza, canine influenza, swine flu, and bird flu, the viral segment is expected to lead the market during the forecast period.
North America is expected to dominate the global market for veterinary vaccines during the forecast period, due to rising incidence of animal diseases and growing population of pets in the U.S.
Key market participants include Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.
Get access to FREE Sample PDF Copy of Veterinary Vaccines Market at https://www.emergenresearch.com/request-sample/426
Regional scope- North America; Europe; Asia Pacific; Central & South America; MEA
Type Outlook (Revenue, USD Billion; 2017–2027)
Administration Path Outlook (Revenue, USD Billion; 2017–2027)
Technology Outlook (Revenue, USD Billion; 2017–2027)
Infection Outlook (Revenue, USD Billion; 2017–2027)
The industry experts have left no stone unturned to identify the major factors influencing the development rate of the Veterinary Vaccines industry including various opportunities and gaps. A thorough analysis of the micro markets with regards to the growth trends in each category makes the overall study interesting. When studying the micro markets the researchers also dig deep into their future prospect and contribution to the Veterinary Vaccines industry.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Veterinary Vaccines Market Segmentation & Impact Analysis
4.1. Veterinary Vaccines Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
126.96.36.199. Stringent environmental regulations
188.8.131.52. Rising need to reduce bacterial or algal contamination in water systems
184.108.40.206. Increasing demand for biocides for municipal water treatment
4.2.3. Market restraints analysis
220.127.116.11. Fluctuating prices of raw material
18.104.22.168. Present challenging economic conditions due to the pandemic
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Veterinary Vaccines Market By Application Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)
Chapter 6. Veterinary Vaccines Market By Product type Insights & Trends Revenue (USD Million), Volume (Kilo Tons)
Chapter 7. Veterinary Vaccines Market Regional Outlook
Chapter 8. Competitive Landscape